Ultragenyx Pharmaceutical...

35.90
0.50 (1.41%)
At close: Apr 22, 2025, 3:59 PM
36.20
0.83%
After-hours: Apr 22, 2025, 07:56 PM EDT

Ultragenyx Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-569.18M -606.64M -707.42M -454.02M -186.57M -402.73M -197.61M -302.14M -245.87M
35.54M 26.01M 18.22M 13.24M 12.26M 8.54M 19.54M 5.83M 3.42M
158.03M 135.21M 130.38M 104.95M 85.73M 82M 80.11M 68.01M 48.31M
n/a 12.23M -5.44M -57.49M 66.57M -12.04M -15.3M -23.69M 23.8M
-38.58M -12.67M 119.76M 11.71M 21.46M 1.69M -156K 10.93M 700K
n/a -1.62M -1.64M 48.67M -169.78M -18.94M -167.65M -16.25M 6.16M
n/a -15.1M 60.23M -63.24M 104.66M -15.94M -24.79M -20.23M 26.3M
-414.19M -474.81M -380.46M -338.69M -132.22M -345.38M -290.57M -253.84M -160.97M
-7.49M -46.77M -146.12M -73.09M -43.91M -24.83M -4.08M -2.79M -10.19M
n/a n/a -75.03M n/a n/a -11.79M n/a -142.8M n/a
-408.61M -526.38M -614.74M -1.01B -850.3M -707.16M -509.8M -230.49M -442.49M
413.27M 746.2M 545.08M 890.85M 720.64M 718.96M 310.22M 431.57M 543.79M
-14.94M -7.55M -844K -942K -5.55M 11.79M 170.32M 934K -1.2M
-17.77M 168M -291.65M -195.37M -179.12M -13.04M -33.33M 56.42M 89.92M
n/a n/a n/a n/a n/a n/a n/a -4.94M n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
18.26M 8.39M 501.21M 39.61M 89.06M 324.06M 27.83M 9.25M 59.19M
399.24M 388.14M 501.21M 118.55M 600.27M 679.31M 336.85M 136.27M 138.68M
-35.24M 81.8M -171.98M -416.71M 290.05M 320.72M 12.48M -60.63M 67.55M
-421.68M -521.57M -526.59M -411.79M -176.13M -370.21M -294.64M -256.64M -171.16M